p100: A novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M

Blood

Volumn 90, Issue 1, 1997, Pages 226-233

  Heidebrecht, H J ^a   Buck, F ^b   Steinmann, J ^b   Sprenger, R ^b   Wacker, H H ^b   Parwaresch, R ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CELL NUCLEUS ANTIGEN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; NUCLEAR PROTEIN;

ARTICLE; BREAST CANCER; CELL CYCLE G2 PHASE; CELL CYCLE PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOMA; METAPHASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0031007610     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.1.226     Document Type: Article

References (40)

1. Marx J: The cell cycle: Spinning farther afield. Science 252:1490, 1991
2. Hirama T, Koeffler HP: Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841, 1995
3. Parwaresch R, Rudolph P: The cell cycle - Theory and applications to cancer. Onkologie 19:464, 1996
4. Gerdes J, Lemke H, Baisch H, Wacker, HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710, 1984
5. Hall PA, Richards MA, Gregory WM, d'Ardenne AJ, Lister TA, Stansfield AG: The prognostic value of Ki-67 immunostaining in non Hodgkin's lymphoma. J Pathol 154:223, 1988
6. Brown DC, Gatter KC: Monoclonal antibody Ki-67: Its use in histopathology. Histopathology 17:489, 1990
7. Kreipe H, Heidebrecht HJ, Hansen S, Röhlk W, Kubbies M, Wacker HH, Tiemann M, Radzun HJ, Parwaresch R: A new proliferation associated nuclear antigen detectable in paraffin-embedded tissue by the monoclonal antibody Ki-S1. Am J Pathol 142:3, 1993
8. Kreipe H, Aim P, Olsson H, Hauberg M, Fischer L, Parwaresch R: Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1. Am J Pathol 142:651, 1993
9. Kreipe H, Wacker HH, Heidebrecht HJ, Haas K, Hauberg M, Tiemann M, Parwaresch R: Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen. Am J Pathol 142:1689, 1993
10. Yu CCW, Filipe MI: Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications. Histochem J 25:843, 1993
11. Quinn CM, Wright NA: The clinical assesment of proliferation and growth in human tumours: Evaluation of methods and applications as prognostic variables. J Pathol 160:93, 1990
12. Scott RJ, Hall PA, Haldane JS, Van Norden S, Price Y, Lane DP, Wright NA: A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 165:173, 1991
13. Morris ES, Elston CW, Bell JA, Galea M, Blamey RW, Ellis IO: An evaluation of cell cycle associated monoclonal antibody Ki-S1 as a prognostic marker in primary invasive adenocarcinoma of the breast. J Pathol 176:55, 1995
14. Boege F, Andersen A, Jensen S, Zeidler R, Kreipe H: Proliferation associated nuclear antigen Ki-S1 is identical with Topoisomerase II alpha. Am J Pathol 146:1302, 1995
15. 1 controls animal cell growth. Proc Natl Acad Sci USA 76:4446, 1979
16. 1 in tumour cells. Cell Prolif 28:33, 1995
17. 1 phase transit by serum during exponential growth. Cell Prolif 28:511, 1995
18. Stansfeld AG: Updated Kiel Classification for Lymphomas. Lancet 1:292, 603, 1988
19. Robb-Smith AHT: U.S. National Cancer Institute Working Formulation of Non Hodgkin's lymphomas for clinical use. Lancet 2:432, 1982
20. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219, 1984
21. Boyum A: Isolation of mononuclear cells and granulocytes from blood. Scand J Clin Lab Invest 21:77, 1968
22. Shapiro HM: Flow cytometric estimation of DNA and RNA in intact cells stained with Hoechst 33342 and Pyronin Y. Cytometry 2:143, 1981
23. Heidebrecht HJ, Buck F, Haas K, Wacker HH, Parwaresch R: Monoclonal antibodies Ki-S3 and Ki-S5 yield new data on the 'Ki-67' proteins. Cell Prolif 29:413, 1996
24. Taagepera S, Rao PN, Drake FH, Gorbsky GJ: DNA topoisomerase II alpha is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2. Proc Natl Acad Sci USA 90:8407, 1993
25. Bauw G, van den Bulcke M, van Damme J, Puype M, van Montagu M, Vandekerckhove J: Protein electroblotting on polybase coated glass-fiber and polyvinylidene difluoride membranes: An evaluation. J Prot Chem 7:194, 1988
26. Kellner U, Heidebrecht HJ, Rudolph P, Buck F, Dakowski T, Wacker HH, Domanowski M, Seidel A, Parwaresch R: Detection of human topoisomerase II alpha in cell lines and tissues - Characterization of five novel monoclonal antibodies. J Histochem Cytochem 45:251, 1997
27. Heidebrecht HJ, Wacker HH, Sprenger R, Parwaresch R: KiS2 detects an antigen expressed almost exclusively during the S, G2 and M phase. Cell Prolif 28:190, 1995
28. Verheijen R, Kuijpers HJH, van Driel R, Beck JLM, van Dierendonk JH, Brakenhoff GJ, Ramaekers FCS: Ki-67 detects a nuclear matrix-associated proliferation-related antigen. Localisation in mitotic cells and association with chromosomes. J Cell Sci 92:531, 1989
29. Zini N, Santi S, Ognibene A, Bavelloni A, Negri LM, Valmori A, Mariani E, Negri C, Astaldi Ricotti GC, Maraldi NM: Discrete localization of different DNA topoisomerases in HeLa and K562 cell nuclei and subnuclear fractions. Exp Cell Res 210:336, 1994
30. Kallajoki M, Weber K, Osborne M: A 210 kDa nuclear matrix protein is a functional part of the mitotic spindle; a microinjection study using SPN monoclonal antibodies. EMBO J 10:3351, 1991
31. Todorov IT, Philipova RN, Joswig G, Werner D, Ramaekers FCS: Detection of the 125 kDa nuclear protein mitotin in centrosomes, the poles of the mitotic spindle, and the midbody. Exp Cell Res 199:398, 1992
32. Srivastava M, Fleming PJ, Pollard HB, Burns AL: Cloning and sequencing of the human nucleolin cDNA. FEBS Lett 250:99, 1989
33. Mackay AM, Eckley DM, Chue C, Earnshaw WC: Molecular analysis of the INCENPs (Inner Centromere Proteins): Separate domains are required for association with microtubules during interphase and with central spindle during anaphase. J Cell Biol 123:373, 1993
34. Draetta G, Beach D: Activation of cdc2 protein kinase during mitosis in human cells: Cell cycle-dependent phosphorylation and subunit rearrangement. Cell 54:17, 1988
35. Saijo M, Ui M, Enomoto T: Growth state and cell cycle dependent phosphorylation of DNA topoisomerase II in Swiss 3T3 cells. Biochemistry 31:359, 1992
36. Prosperi E, Scovassi I, Stivala LA, Bianchi L: Proliferating cell nuclear antigen bound to DNA synthesis sites: Phosphorylation and association with cyclin D1 and cyclin A. Exp Cell Res 215:257, 1994
37. Wilson GD, Saunders M, Dische S, Daley FM, Robinson BM, Martindale CA, Joiner B, Richman PI: Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours. Cell Prolif 29:141, 1996
38. Hall PA, Levison DA: Assessment of cellular proliferation in histological material. J Clin Pathol 43:184, 1990
39. Hofstädter F, Knüchel R, Rüschoff J: Cell proliferation assessment in oncology. Virchows Arch 427:323, 1995
40. Gerdes J, Dallenbach F, Lennert K: Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Br J Haematol 65:271, 1984